Boston University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Boston University sits in the top decile of US sponsors by registered trial count (#161 of 15,742 sponsors by registered trial count).
Boston University: 185 sponsored US clinical trials, 23 recruiting.
Boston University sponsors 185 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 125 completed. 12 of these trials are in Phase 3-4 (later-stage) and 35 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 3 trials.
Top-decile sponsor footprint
Boston University ranks in the top decile of sponsors by registered trial count (#161 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
125 of 148 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
185 total, page 2 of 4
Evaluating the Effect of SOLIUS UV Light Source in Improving Vitamin D Status
NCT04780776
Social Media and Risk Reduction Teaching-Enhanced Reach
NCT04387552
Boston ARCH 4F Intervention to Reduce Fall Risk in People With HIV and Alcohol Use
NCT04804579
Solius UV Light Source in Improving Serum Levels of 25-hydroxyvitamin D
NCT04865432
Second eFramngham Heart Study
NCT04752657
Geriatric Anorexia Study
NCT04858932
RECLEAN Pilot Study
NCT04498845
Virtual Teaching Kitchen
NCT04509206
Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults
NCT04480112
Awake Prone Position for Early Hypoxemia in COVID-19
NCT04344587
Young Men and Media Study
NCT04109443
Usability Study of a Smoking Cessation Intervention During a Dental Cleaning
NCT04247061
Reducing Health Disparities for Black Women in the Treatment of Insomnia
NCT03613519
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
NCT03698669
Scratch Behavior Under Standard of Care
NCT03898427
Inpatient Smokers and LDCT Screening Part 2
NCT03793894
Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia
NCT03996967
Exercise Maintenance in Chronic Pain and PTSD
NCT03644927
Monitoring Of Scratch Via Accelerometry In Children
NCT03873220
Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)
NCT03591757
25-Hydroxyvitamin D Pharmacokinetic Study
NCT03401541
eFHS Messaging Trial
NCT03516019
Effects of TUDCA on Endothelial Function in Type 2 DM
NCT03462940
Interactive Parent-Targeted Text Messaging in Pediatric Clinics to Reduce Caries Among Urban Children
NCT03294590
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort: The 4F Study
NCT03414411
The Entorhinal Cortex and Aerobic Exercise in Aging
NCT02775760
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages
NCT02856776
Inpatient Smokers and LDCT Screening RCT
NCT03276806
Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP)
NCT03062111
Bio Electro Stimulation Therapy for Parkinson's Disease
NCT03014050
Genetics of Ehlers-Danlos Syndrome
NCT03093493
Self-Management Using Text Messaging in a Homeless Population
NCT03034993
eOnOff - D1 Extension
NCT03247387
Physical Activity and Cognition Study
NCT02773121
The Treatment of Depression With Yoga and Walking
NCT02907476
Spinal Cord Injury Virtual Coach RCT
NCT02876666
A Community-based Study to Target Childhood Obesity
NCT02890056
The DIAGNOSE-CTE Research Project
NCT02798185
Alcohol Disorder hOsPital Treatment Trial
NCT02478489
Evaluation of a Device That Separates Blood Cells From Serum/Plasma
NCT02853448
Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease
NCT02521558
Dietary Approaches to Stopping Hypertension (DASH) Mobile App Pilot
NCT02214459
Macitentan in Pulmonary Hypertension of Sickle Cell Disease
NCT02651272
Project EARLY: Engagement, Assessment, Referral, & Linkage for Young Children
NCT02359084
Effectiveness of a Unified Transdiagnostic Treatment in Routine Care
NCT02944994
Theory of Planned Behavior and Implementation Intentions
NCT02205697
A Brief Intervention to Prevent Adolescent Dating Aggression Perpetration
NCT02080923
Neuroimaging Study of Exercise and Memory Function
NCT02057354
A Novel Motivational Ecological Momentary Intervention for Anorexia Nervosa
NCT02076854
Dose-Dependent Effects of Erythritol on Endothelial Function in Type 2 Diabetes Mellitus
NCT01908348
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 19 |
| Phase 2 | 16 |
| Phase 3 | 4 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Boston University pipeline
23 recruiting of 185 indexed (12% open); 125 completed (68%).
Phase mix: 12 late (III/IV) vs 35 early (I/II) (early-phase heavy).
Top condition: HIV Infections (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Boston University: open-pipeline peers nationwide
Peers matched on 185 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Boston University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 185 trials (± recruiting share)
- National Human Genome Research Institute (NHGRI) · 185 trials · 16% recruiting
- Children's Mercy Hospital Kansas City · 184 trials · 11% recruiting
- Arizona State University · 187 trials · 15% recruiting
- Johns Hopkins Bloomberg School of Public Health · 187 trials · 14% recruiting
Sponsors near 12% open enrollment (± trial volume)
- AstraZeneca · 12% recruiting · 1,285 trials
- National Heart, Lung, and Blood Institute (NHLBI) · 12% recruiting · 501 trials
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
Related
What to do with this Boston University page
185 registered trials is a research-attention snapshot, not an endorsement of Boston University or any single study.
- 23 of Boston University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- HIV Infections is the condition Boston University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Boston University pipeline card: 185 registered trials from official public datasets.Report a data error.